AMRX - Amneal Pharmaceuticals, Inc.

13.26
-0.650   -4.902%

Share volume: 1,631,581
Last Updated: 04-20-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.17%

PREVIOUS CLOSE
CHG
CHG%
$13.91
-0.65
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 12-31-2025
Fiscal Quarter Q4 2025
Report Date 02-27-2026
Total revenue 814.319 M
Cost of revenue 517.129 M
Gross profit 297.190 M
     
Operating expenses 182.688 M
Selling general and admin 146.458 M
Research and development 36.230 M
Total expenses 185.157 M
     
Operating income 112.033 M
Ebit 111.472 M
Pretax income 55.235 M
     
Income tax 5.662 M
Net income basic 0.000
     
Net income 49.573 M